Leadership Overview
Viatris has 10 executives leading key functions including strategy, finance, marketing, operations, and technology.
Driven by a commitment to patient health, Viatris empowers individuals globally with access to essential medicines, fosters sustainable operations, and pioneers innovative healthcare solutions through collective expertise.
Driven by a commitment to patient health, Viatris empowers individuals globally with access to essential medicines, fosters sustainable operations, and pioneers innovative healthcare solutions through collective expertise.
Leadership Roles at Viatris
Paul Campbell - Interim Chief Financial Officer
Paul Campbell, the Interim Chief Financial Officer at Viatris, directs financial strategy and fiscal management to support global operations. Overseeing all financial planning, reporting, and investment activities, Campbell ensures robust fiscal health for the organization. This critical role involves managing capital allocation and driving financial discipline to enable Viatris's mission of providing access to medicines. By optimizing financial resources, Paul Campbell directly supports the company's sustainable operations and development of innovative solutions. Ultimately, Campbell safeguards the financial stability required for Viatris to empower healthier lives worldwide.
Zac Walters - Chief of Staff To the Chief Financial Officer
Zac Walters, the Chief of Staff To the Chief Financial Officer at Viatris, provides strategic support and operational oversight for financial functions. Assisting the CFO in managing fiscal planning and resource allocation, Walters ensures alignment with Viatris's broader business objectives. This role involves facilitating communication between finance and other departments to drive efficiency and support sustainable operations. By streamlining financial processes, Zac Walters directly contributes to the company's capacity to invest in innovative solutions. Ultimately, Walters enhances the financial agility necessary for Viatris to expand global access to medicines.
Tj Valerio - Chief of Staff To the Chief Financial Officer
Tj Valerio, the Chief of Staff To the Chief Financial Officer at Viatris, supports the CFO in executing financial strategies and managing operational efficiencies. Collaborating closely with the finance team, Valerio facilitates the implementation of fiscal policies and drives key financial projects. This role is integral to ensuring Viatris maintains robust financial health while pursuing its mission of global healthcare access. By enhancing financial coordination, Tj Valerio directly contributes to the company's capacity for sustainable operations and innovation. Ultimately, Valerio strengthens the financial infrastructure supporting Viatris's commitment to patient well-being worldwide.
Kristin DiBartolomeo - Chief of Staff
Kristin DiBartolomeo, the Chief of Staff at Viatris, directs strategic initiatives and operational alignment across key departments. Overseeing critical projects, DiBartolomeo ensures seamless execution of Viatris's mission to provide global access to medicines. This leadership role involves close collaboration with executive leadership to drive efficiency and advance sustainable operations. By optimizing internal processes, Kristin DiBartolomeo directly supports the company's commitment to improving patient health worldwide. Ultimately, DiBartolomeo enhances the company's ability to deliver innovative solutions at every stage of life.
Nicolette O'Rourke - Chief of Staff & Office of Administrative Chief & Transformation Officer
Nicolette O'Rourke, the Chief of Staff & Office of Administrative Chief & Transformation Officer at Viatris, spearheads administrative functions and drives organizational transformation. Managing key administrative operations, O'Rourke ensures efficient support for executive leadership and facilitates strategic change initiatives. This position involves enhancing operational frameworks to align with Viatris's goals of advancing sustainable operations and developing innovative solutions. By streamlining administrative processes, Nicolette O'Rourke directly contributes to the company's capacity to improve patient health globally. Ultimately, O'Rourke strengthens the company's infrastructure for delivering accessible medicines.
Jeff Wallace - Chief of Staff & Chief Supply Officer (Office of Supply)
Jeff Wallace, the Chief of Staff & Chief Supply Officer (Office of Supply) at Viatris, orchestrates global supply chain operations and strategic sourcing. Managing the end-to-end supply network, Wallace ensures the reliable delivery of medicines to patients worldwide. This leadership position involves optimizing logistics, inventory management, and supplier relationships to advance Viatris's commitment to sustainable operations. By enhancing supply chain resilience, Jeff Wallace directly supports the company's ability to provide consistent access to essential treatments. Ultimately, Wallace drives operational excellence critical for improving patient health at every life stage.
Kübra Kunt - Chief Marketing Officer, Quality Assurance & Senior Specialist
Kübra Kunt, the Chief Marketing Officer, Quality Assurance & Senior Specialist at Viatris, directs global marketing strategies and ensures stringent quality assurance standards. Overseeing brand development and market positioning, Kunt drives Viatris's mission to empower healthier lives through accessible medicines. This multifaceted role involves integrating quality management with marketing initiatives to enhance patient trust and product integrity. By championing quality and effective communication, Kübra Kunt directly supports the company's commitment to developing innovative solutions. Ultimately, Kunt elevates Viatris's market presence while upholding the highest standards of product safety and efficacy.
Florence Wright - Head of Global Compliance Risk, Transparency & Due Diligence Chief of Staff
Florence Wright, the Head of Global Compliance Risk, Transparency & Due Diligence Chief of Staff at Viatris, leads the development and implementation of comprehensive compliance programs. Overseeing risk management and due diligence processes, Wright ensures adherence to global regulatory standards and ethical practices. This critical function supports Viatris's commitment to advancing sustainable operations and maintaining transparency. By fortifying compliance frameworks, Florence Wright directly contributes to the company's reputation and its ability to operate responsibly worldwide. Ultimately, Wright safeguards Viatris's integrity, enabling the consistent delivery of safe and effective medicines.
Holly Howes - Chief of Staff & Supply Chief & Officer
Holly Howes, the Chief of Staff & Supply Chief & Officer at Viatris, drives strategic alignment and operational execution within the supply chain division. Managing key supply initiatives, Howes ensures the efficient and reliable distribution of Viatris's pharmaceutical products globally. This leadership role focuses on enhancing supply chain resilience and optimizing resource utilization to support the company's mission. By coordinating supply operations, Holly Howes directly contributes to Viatris's ability to provide consistent access to essential medicines. Ultimately, Howes strengthens the operational backbone necessary for improving patient health at every stage of life.
Ramkumar Rayapureddy - Global Chief Information Officer
Ramkumar Rayapureddy, the Global Chief Information Officer at Viatris, directs the company's technology strategy and digital transformation initiatives. Overseeing all IT infrastructure, cybersecurity, and data management, Rayapureddy ensures robust technological support for global operations. This leadership position is crucial for advancing Viatris's mission to develop innovative solutions and improve patient health through digital enablement. By leveraging cutting-edge technology, Ramkumar Rayapureddy directly supports the company's commitment to sustainable operations and efficient medicine delivery. Ultimately, Rayapureddy drives technological advancements that empower Viatris to expand access to healthcare worldwide.
Explore Leadership Teams in Manufacturing
Sun Pharma is a specialty generic pharmaceutical company that manufactures and distributes pharmaceutical formulations and active pharmaceutical ingredients. It is heaquartered in Mumbia, India.
Company Leadership LK
FN
KS
AbbVie Inc. is a global biopharmaceutical company dedicated to discovering, developing, and delivering innovative medicines and health solutions that address some of the worlds most complex medical challenges. Headquartered in North Chicago, Illinois, the company operates internationally and focuses on advancing treatments that improve patient outcomes and overall quality of life. AbbVies scientific and commercial efforts are concentrated in several core therapeutic areas, including immunology, oncology, neuroscience, eye care, and medical aesthetics, along with other specialty areas where significant unmet medical needs exist. Through these focus areas, the company works to create therapies that help patients manage chronic, serious, and often life-altering diseases.
Company Leadership CS
MK
MB
MH
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. Its marketed products include ONPATTRO (patisiran) for the treatment of the polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; AMVUTTRA for the treatment of hATTR amyloidosis with polyneuropathy in adults; GIVLAARI for the treatment of adults with acute hepatic porphyria; and OXLUMO for the treatment of primary hyperoxaluria type 1. In addition, the company develops patisiran for the treatment of transthyretin amyloidosis, or ATTR amyloidosis, with cardiomyopathy; cemdisiran to treat complement-mediated diseases; Belcesiran for the treatment of alpha-1 liver disease; Elebsiran to treat chronic HBV infection; Zilebesiran to treat hypertension; ALN-APP to treat Alzheimer's disease and cerebral amyloid angiopathy; and ALN-HSD to treat NASH. Further, it offers Fitusiran for the treatment of hemophilia, Inclisiran to treat hypercholesterolemia, lumasiran for the treatment of advanced PH1, and vutrisiran for the treatment of ATTR amyloidosis, which is in phase 3 clinical trial. Alnylam Pharmaceuticals, Inc. has strategic collaborations with Regeneron Pharmaceuticals, Inc. to discover, develop, and commercialize RNAi therapeutics for a range of diseases by addressing therapeutic targets expressed in the eye and CNS; and Roche to develop pharmaceutical products containing zilebesiran. It also has license and collaboration agreements with Novartis AG; Vir Biotechnology, Inc.; Dicerna Pharmaceuticals, Inc.; Ionis Pharmaceuticals, Inc.; and PeptiDream, Inc. The company was founded in 2002 and is headquartered in Cambridge, Massachusetts.
Company Leadership
Sandoz Group AG (SIX: SDZ) is a global healthcare company focused on developing, manufacturing, and delivering high-quality generic medicines and biosimilars. Serving patients worldwide, Sandoz provides treatments across multiple therapeutic areas, including oncology, immunology, and cardiovascular health.
Company Leadership AJ
EM
BE
BP
Frequently Asked Questions Regarding Viatris Top Executives and Leadership Team
